Anixa Biosciences Inc
Anixa Biosciences Inc (ANIX) Straddle
ANIX straddle scan found 1 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 64.3%.
Read more
Trading a ANIX straddle lets you take a pure volatility position on Anixa Biosciences Inc without committing to a direction. Anixa Biosciences Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ANIX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on ANIX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Anixa Biosciences Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ANIX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer.
The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the ANIX straddle is the cleanest expression of that view. Our scanner prices every ANIX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ANIX straddle into a catalyst or short a ANIX straddle to harvest decay, the options straddle setups that matter are all in one place.
| Jan 15, 2027 | 5.00 | $2.85 | 119 | 31% | 64.3% | $7.85 | $2.15 | 4 |
As of September 22, 2026
Find the right straddle before volatility moves
Track ANIX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→